drugset / Trial / NCT07034781
A Study to Evaluate the Safety and Pharmacokinetics of Dapagliflozin, Linagliptin, and Metformin in Healthy Adults
RandomizedCrossoverOpen-labelTreatment
Summary
To Evaluate the Safety and Pharmacokinetics of Dapagliflozin, Linagliptin, and Metformin in Healthy Adults
Timeline
- Start
- 2025-08
- Primary completion
- 2025-11
- Completion
- 2025-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AJU-A53 | Unknown | — | Oral |
| Subject | Dapagliflozin | Small molecule | 10 mg | Oral |
| Subject | Linagliptin | Small molecule | 5 mg | Oral |
| Subject | Metformin | Small molecule | 1000 mg | Oral |